IT1174800B - Metodo per la determinazione di immunoglobuline umane specifiche per gli antigeni dei carcinomi umani e sua utilizzazione nella sierodiognosi di forme primitive tumorali - Google Patents

Metodo per la determinazione di immunoglobuline umane specifiche per gli antigeni dei carcinomi umani e sua utilizzazione nella sierodiognosi di forme primitive tumorali

Info

Publication number
IT1174800B
IT1174800B IT49370/83A IT4937083A IT1174800B IT 1174800 B IT1174800 B IT 1174800B IT 49370/83 A IT49370/83 A IT 49370/83A IT 4937083 A IT4937083 A IT 4937083A IT 1174800 B IT1174800 B IT 1174800B
Authority
IT
Italy
Prior art keywords
human
determination
immunoglobulins specific
tumor forms
carcinoma antigens
Prior art date
Application number
IT49370/83A
Other languages
English (en)
Other versions
IT8349370A0 (it
Inventor
Alberto Bartorelli
Original Assignee
Alberto Bartorelli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alberto Bartorelli filed Critical Alberto Bartorelli
Priority to IT49370/83A priority Critical patent/IT1174800B/it
Publication of IT8349370A0 publication Critical patent/IT8349370A0/it
Priority to US06/671,370 priority patent/US4732862A/en
Priority to GB08428964A priority patent/GB2151781B/en
Priority to JP59245863A priority patent/JPS60138469A/ja
Priority to FR8417650A priority patent/FR2555755B1/fr
Priority to DE3442858A priority patent/DE3442858C2/de
Application granted granted Critical
Publication of IT1174800B publication Critical patent/IT1174800B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3007—Carcino-embryonic Antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57473—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving carcinoembryonic antigen, i.e. CEA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Optics & Photonics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Analytical Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IT49370/83A 1983-11-21 1983-11-21 Metodo per la determinazione di immunoglobuline umane specifiche per gli antigeni dei carcinomi umani e sua utilizzazione nella sierodiognosi di forme primitive tumorali IT1174800B (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT49370/83A IT1174800B (it) 1983-11-21 1983-11-21 Metodo per la determinazione di immunoglobuline umane specifiche per gli antigeni dei carcinomi umani e sua utilizzazione nella sierodiognosi di forme primitive tumorali
US06/671,370 US4732862A (en) 1983-11-21 1984-11-14 Determination of CEA binding substance using anti-goat immunoglobulins
GB08428964A GB2151781B (en) 1983-11-21 1984-11-16 Determination of human immunoglobulin
JP59245863A JPS60138469A (ja) 1983-11-21 1984-11-20 腫瘍特異的免疫グロブリンの測定法
FR8417650A FR2555755B1 (fr) 1983-11-21 1984-11-20 Procede de dosage des immunoglobulines humaines qui sont specifiques d'antigenes cancereux humains et application de ce procede dans le serodiagnostic de maladies tumorales primitives
DE3442858A DE3442858C2 (de) 1983-11-21 1984-11-22 Verfahren zur bestimmung eines menschlichen immunglobulins, das spezifisch ist fuer menschliche karzinome

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT49370/83A IT1174800B (it) 1983-11-21 1983-11-21 Metodo per la determinazione di immunoglobuline umane specifiche per gli antigeni dei carcinomi umani e sua utilizzazione nella sierodiognosi di forme primitive tumorali

Publications (2)

Publication Number Publication Date
IT8349370A0 IT8349370A0 (it) 1983-11-21
IT1174800B true IT1174800B (it) 1987-07-01

Family

ID=11270493

Family Applications (1)

Application Number Title Priority Date Filing Date
IT49370/83A IT1174800B (it) 1983-11-21 1983-11-21 Metodo per la determinazione di immunoglobuline umane specifiche per gli antigeni dei carcinomi umani e sua utilizzazione nella sierodiognosi di forme primitive tumorali

Country Status (6)

Country Link
US (1) US4732862A (it)
JP (1) JPS60138469A (it)
DE (1) DE3442858C2 (it)
FR (1) FR2555755B1 (it)
GB (1) GB2151781B (it)
IT (1) IT1174800B (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2675117B2 (ja) * 1988-05-13 1997-11-12 森永製菓株式会社 がんの血清測定法
US5278290A (en) * 1991-05-31 1994-01-11 Applied Biotechnology, Inc. Binding protein for CEA and uses thereof
US5281697A (en) * 1991-05-31 1994-01-25 Applied Biotechnology, Inc. CEA-binding protein and uses thereof
WO1992021364A1 (en) * 1991-05-31 1992-12-10 New England Deaconess Hospital Corporation Cea-binding proteins and methods for their isolation and use
US5790761A (en) * 1992-12-11 1998-08-04 Heseltine; Gary L. Method and apparatus for the diagnosis of colorectal cancer
WO1994018562A1 (en) * 1993-02-05 1994-08-18 Epigen, Inc. Human carcinoma antigen (hca), hca antibodies, hca immunoassays, methods of imaging and therapy
US6409473B1 (en) 2000-06-27 2002-06-25 Honeywell International, Inc. Low stress connection methodology for thermally incompatible materials
US20070022873A1 (en) * 2005-07-26 2007-02-01 Honeywell International Inc. Wear-resistant port plate for a fluid transfer device and fluid transfer device including same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4145336A (en) * 1976-04-30 1979-03-20 Scripps Clinic And Research Foundation Carcinoembryonic antigen isomer
US4178359A (en) * 1976-10-12 1979-12-11 Hoffmann-La Roche Inc. Immunoassay method
US4146603A (en) * 1977-02-18 1979-03-27 Research Corporation Tumor specific glycoproteins and method for detecting tumorigenic cancers
US4349528A (en) * 1979-11-21 1982-09-14 The Wistar Institute Monocolonal hybridoma antibody specific for high molecular weight carcinoembryonic antigen
US4299815A (en) * 1980-02-08 1981-11-10 Hoffmann-La Roche Inc. Carcinoembryonic antigen determination
US4348376A (en) * 1980-03-03 1982-09-07 Goldenberg Milton David Tumor localization and therapy with labeled anti-CEA antibody

Also Published As

Publication number Publication date
FR2555755A1 (fr) 1985-05-31
GB2151781B (en) 1988-01-06
DE3442858C2 (de) 1993-11-04
GB8428964D0 (en) 1984-12-27
FR2555755B1 (fr) 1989-01-13
JPS60138469A (ja) 1985-07-23
US4732862A (en) 1988-03-22
GB2151781A (en) 1985-07-24
IT8349370A0 (it) 1983-11-21
DE3442858A1 (de) 1985-05-30

Similar Documents

Publication Publication Date Title
US4609548B1 (en) Vaccines for pseudorabies disease and methods for use of same
IT1155211B (it) Emulsioni di clorobromuro di argento e procedimenti per la loro preparazione
DE3380089D1 (en) Ultrasonic blood flow imaging method and apparatus
IT1144580B (it) Corredo per al diagnosi rapida presuntiva di uretriti gonococciche e procedimento per il suo impiego
ES531717A0 (es) Perfeccionamientos en la fabricacion de bolsas para fluidos de aplicacion medica
AU551967B2 (en) Method for the identification and purification of human lung tumor-associated antigens (hltaa) and clinical detection anddetermination of these antigens
AR227559A1 (es) Metodo para desodorizar composiciones cosmeticas y terapeuticas
GB2152215B (en) Method for the quantitative determination of physiological components in biological fluids
NO830570L (no) Antistoffer og antigener for diagnose og behandling av cancer
DE3888998D1 (de) Verfahren zur Bestimmung eines Antikörpers in menschlichen Körperflüssigkeiten.
IT1152924B (it) Sacchetto medico e metodo per la fabbricazione dello stesso
IT1174800B (it) Metodo per la determinazione di immunoglobuline umane specifiche per gli antigeni dei carcinomi umani e sua utilizzazione nella sierodiognosi di forme primitive tumorali
OA08313A (fr) Appareil pour déterminer la période d'ovulation chez la femme.
IT1142029B (it) Preparato cosmetico e procedimento per la sua preparazione
IT1173473B (it) Procedimento per la preparazione di 1,8-diidrossi-10-acil-9-antroni,in particolare per l'uso nel trattamento di psoriasi
IT1156478B (it) Procedimento per la preparazione di acril e metacril ammidi
ES525849A0 (es) Metodo para la preparacion y purificacion de concentrados de factor viii antihemofilia de la sangre
RO86230A (ro) Metoda si aparat pentru administrarea hranei la porcine
IT1145624B (it) Mola di rettifica e procedimento per la sua fabbricazione
NO843105L (no) Hjulsonde for ultrasonisk undersoekelse
ES514387A0 (es) "metodo para la determinacion de las proteinas glicosiladas presentes en fluidos biologicos".
FR2492250B1 (fr) Appareil pour mesurer le profil de la colonne vertebrale du corps humain notamment
IT1170862B (it) Mercaptoacil-carnitine procedimento per la loro preparazione e loro uso terapeutico
GB2114288B (en) Method for the detection of malaria antigens in human blood
IT1170517B (it) Perfezionamento negli shampoo per il condizionamento dei capelli

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19961023